Pfizer Inc. is cutting at least another $1.2 billion from its spending while the company searches for its next big hit after ...

We recently published a list of Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500. In this ...

Pfizer got a reprieve in January when Starboard didn’t nominate its own slate of directors to the company’s board, but the activist could still agitate for changes next year.

Activist investor Starboard Value has launched a broadside against Pfizer's leadership under chief executive Albert Bourla, claiming at least $20 billion in value – and possibly as much as $60 ...

We recently published a list of 15 Recent Activist Investor Campaigns. In this article, we are going to take a look at where ...

Pfizer Inc. (NYSE:PFE) is a pharmaceutical giant that discovers, develops, and provides medicines and vaccines to improve people’s lives. Activist hedge fund Starboard Value LP amassed a $1 ...

Pfizer will halt its development of a weight-loss drug that was being closely watched by investors, in a significant blow to the US pharmaceutical group. The company said on Monday that it would stop ...

Pfizer chief executive Albert Bourla hit back at Starboard Value in its third-quarter results call, criticising the activist investor for complaining about the company's direction without coming ...

The American hedge fund Starboard Value has acquired a stake in Pfizer Inc. worth $1 billion. This is reported in the Starboard Value press release. Starboard Value is committed to accelerating the ...